Researchers Develop Tool To Help Study Prostate Cancer

Van Andel Research Institute (VARI) researchers have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer. Using the model, they found that normal cells and cancer cells depend on different factors to survive, which could aid in discovering how to target cancer cells without affecting normal cells when developing treatments. Prostate cancer is the most common form of cancer in men, with more than 192,000 new cases and more than 27,000 deaths reported in the United States in 2009 (Source: National Cancer Institute)…

Go to Source

People who read this also read

• PSA Remains An Important Tool For Fighting Cancer Says Prostate Cancer Foundation
  Responding to continued debate over PSA screening, and today's American Cancer Society statement, the Prostate Cancer Foundation (PCF) reiterated its position that PSA screening remains a valuable tool, in combination with other tools, for identifying potential prostate disease, including cancer. It...
• Researchers Develop Tool To Measure Severity Of Chronic Graft-Versus-Host Disease Symptoms
  Researchers from The University of Texas M. D. Anderson Cancer Center have developed a new assessment tool to measure the severity of symptoms that can complicate stem cell transplantation. The tool assesses symptoms resulting from chronic graft-versus-host disease (cGVHD), and was presented with su...
• When To Perform Bone Scan In Patients With Newly Diagnosed Prostate Cancer: Validation Of Available Guidelines, Risk Stratification Tool Proposal
  UroToday.com - Prostate cancer (CaP) patients often undergo a routine bone scan as part of their metastatic evaluation at the time of diagnosis. Most consensus recommendations suggest obtaining bone scans only in patients with risk characteristics suggesting reasonable utility for this test. Howev...
• MU Researchers Collaborate To Develop Standard Of Care For Breast Cancer Survivors With Lymphedema
  Lymphedema, a chronic swelling condition that can appear after breast cancer surgery, is a risk for 1.3 million breast cancer survivors. Although lymphedema can cause lifelong swelling in the arms, back, neck and chest, there is no national standard of diagnosis or care. Now, University of Missouri ...
• Advaxis’ Live Listeria Prostate Cancer Vaccine Heads For Clinic
  Advaxis, Inc., (OTCBB: ADXS). Advaxis, the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, is advancing the clinical development of its lead prostate cancer immunotherapeutic toward clinical trials. The company is collaborating with Dr. Chandan Guha at the Albert Einstein Colleg...